Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,227 | 5,943 | 5,748 | 7,463 | 5,085 |
| Other current assets | 475 | 269 | 340 | 364 | 370 |
| TOTAL | $4,702 | $6,212 | $6,088 | $7,827 | $5,455 |
| Non-Current Assets | |||||
| PPE Net | 52 | 66 | 166 | 490 | 605 |
| Other Non-Current Assets | 204 | 224 | 244 | 264 | 284 |
| TOTAL | $256 | $290 | $410 | $754 | $889 |
| Total Assets | $4,958 | $6,502 | $6,498 | $8,581 | $6,344 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 126 | 260 | 284 | 517 | 711 |
| Accrued Expenses | 78 | 461 | 345 | 454 | 704 |
| Other current liabilities | 357 | N/A | N/A | N/A | N/A |
| TOTAL | $594 | $754 | $661 | $1,004 | $1,538 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33 | 33 | 32 | 33 | 123 |
| TOTAL | $8 | $16 | $25 | $32 | $163 |
| Total Liabilities | $602 | $770 | $686 | $1,036 | $1,701 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 1 | 1 |
| Common Shares | 12 | 2 | 11 | 11 | 9 |
| Retained earnings | -65,081 | -63,674 | -62,044 | -60,222 | -60,516 |
| TOTAL | $4,356 | $5,732 | $5,812 | $7,545 | $4,643 |
| Total Liabilities And Equity | $4,958 | $6,502 | $6,498 | $8,581 | $6,344 |